Risk Flags
extreme_brand_preference
Risk indicators are statistical patterns, not allegations. Learn more
572,481
Total Claims
$137.1M
Drug Cost
417,661
Beneficiaries
$328
Cost/Patient
Risk Score Breakdown 9/100
Low (0)Moderate (15)Elevated (30)High (50+)
Brand-name preference+8
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-100%
Opioid rate vs peers
0.0% vs 2.6% avg
-69%
Cost per patient vs peers
$328 vs $1,068 avg
+1000%
Brand preference vs peers
99.0% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
1% generic
Brand: 566,752 claims · $136.7M
Generic: 5,693 claims · $408K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 177,334 | $56.5M |
| Varicella-Zoster Ge/As01b/Pf | 259,030 | $55.8M |
| Rsv Vacc, Pref A And Pref B/Pf | 54,336 | $17.7M |
| Diphth,pertuss(Acell),tet Vac | 52,002 | $3.5M |
| Hepatitis A And B Vaccine/Pf | 12,571 | $1.9M |
| Naloxone Hcl | 5,633 | $455K |
| Diph,pertuss(Acell),tet Vac/Pf | 4,416 | $307K |
| Hepatitis A Virus Vaccine/Pf | 1,706 | $178K |
| Mening Vac A,c,y,w135,c-Tet/Pf | 538 | $100K |
| Hpv Vaccine 9-Valent/Pf | 309 | $96K |
| Typhoid Vi Polysacch Vaccine | 597 | $81K |
| Measles,mumps,rubella Vacc/Pf | 636 | $73K |
| Varicella Vaccine Live/Pf | 188 | $37K |
| Tetanus-Diphtheria Toxoids/Pf | 597 | $36K |
| Yellow Fever Vaccine Live/Pf | 158 | $33K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
1.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About